Loading…

Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever

Background: A number of inflammatory diseases, including familial Mediterranean fever (FMF), have been shown to be driven by a strongly dominated Th1 response, whereas the pathogenesis of atopic diseases is associated with a Th2 response. Objective: Because dominance of interferon gamma has the pote...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the rheumatic diseases 2004-02, Vol.63 (2), p.187-190
Main Authors: Sackesen, C, Bakkaloglu, A, Sekerel, B E, Ozaltin, F, Besbas, N, Yilmaz, E, Adalioglu, G, Ozen, S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b625t-1b60bb4e35c3372b155ee270f74664dd9f8107b083c16dcb442047f0e704f0593
cites
container_end_page 190
container_issue 2
container_start_page 187
container_title Annals of the rheumatic diseases
container_volume 63
creator Sackesen, C
Bakkaloglu, A
Sekerel, B E
Ozaltin, F
Besbas, N
Yilmaz, E
Adalioglu, G
Ozen, S
description Background: A number of inflammatory diseases, including familial Mediterranean fever (FMF), have been shown to be driven by a strongly dominated Th1 response, whereas the pathogenesis of atopic diseases is associated with a Th2 response. Objective: Because dominance of interferon gamma has the potential of inhibiting Th2 type responses—that is, development of allergic disorders, to investigate whether FMF, or mutations of the MEFV gene, have an effect on allergic diseases and atopy that are associated with an increased Th2 activity. Method: Sixty children with FMF were questioned about allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis, as were first degree relatives, using the ISAAC Study phase II questionnaire. The ISAAC Study phase II was performed in a similar ethnic group recruited from central Anatolia among 3041 children. The same skin prick test panel used for the ISAAC Study was used to investigate the presence of atopy in patients with FMF and included common allergens. Results: The prevalences of doctor diagnosed asthma, allergic rhinitis, and eczema were 3.3, 1.7, and 3.3%, respectively, in children with FMF, whereas the corresponding prevalences in the ISAAC study were 6.9, 8.2, and 2.2%, respectively. Only the prevalence of allergic rhinitis was significantly different between the two groups (p
doi_str_mv 10.1136/ard.2003.007013
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A112941610</galeid><sourcerecordid>A112941610</sourcerecordid><originalsourceid>FETCH-LOGICAL-b625t-1b60bb4e35c3372b155ee270f74664dd9f8107b083c16dcb442047f0e704f0593</originalsourceid><addsrcrecordid>eNqFkk1vEzEQhlcIREPhzA2thOCAtOn4Y-3dS6UqpRQRyqX0anm949Rhv7A3afvvcZSooSgS2oPXnmdez4zfJHlLYEoIEyfa11MKwKYAEgh7lkwIF0VGQcDzZAIxkvFSyKPkVQjLuIWCFC-TI8IlpRTKSXJzjsajDling8e1brAzmPY21WM_PKSuSweNtdOjdyb-jg67MaR3brxNrW5d43STfo_AiN7rDnWXWlyjf528sLoJ-Ga3Hic_Lz5fzy6z-Y8vX2dn86wSNB8zUgmoKo4sN4xJWpE8R6QSrORC8LoubUFAVlAwQ0RtKs4pcGkBJXALecmOk9Ot7rCqWqxNrM7rRg3etdo_qF479TTSuVu16NeKyJwXBY8CH3cCvv-9wjCq1gWDTROb6VdBFQAlYWQDvv8HXPYr38XmopaUBc9LQffUIk5Suc728VazkVRnhNCSE0EgUtkBaoEdxhL7Dq2Lx0_46QE-fjW2zhxMONkmGN-H4NE-ToSA2hhHReOojXHU1jgx493fg9zzO6dE4MMO0MHoxsbXNi7suZwzyZjY9-bCiPePce1_KSGZzNXVzUyVxfzy_NvFtbqK_KctX7XL_1b5BzUp5WI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777845962</pqid></control><display><type>article</type><title>Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever</title><source>PubMed Central</source><creator>Sackesen, C ; Bakkaloglu, A ; Sekerel, B E ; Ozaltin, F ; Besbas, N ; Yilmaz, E ; Adalioglu, G ; Ozen, S</creator><creatorcontrib>Sackesen, C ; Bakkaloglu, A ; Sekerel, B E ; Ozaltin, F ; Besbas, N ; Yilmaz, E ; Adalioglu, G ; Ozen, S</creatorcontrib><description>Background: A number of inflammatory diseases, including familial Mediterranean fever (FMF), have been shown to be driven by a strongly dominated Th1 response, whereas the pathogenesis of atopic diseases is associated with a Th2 response. Objective: Because dominance of interferon gamma has the potential of inhibiting Th2 type responses—that is, development of allergic disorders, to investigate whether FMF, or mutations of the MEFV gene, have an effect on allergic diseases and atopy that are associated with an increased Th2 activity. Method: Sixty children with FMF were questioned about allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis, as were first degree relatives, using the ISAAC Study phase II questionnaire. The ISAAC Study phase II was performed in a similar ethnic group recruited from central Anatolia among 3041 children. The same skin prick test panel used for the ISAAC Study was used to investigate the presence of atopy in patients with FMF and included common allergens. Results: The prevalences of doctor diagnosed asthma, allergic rhinitis, and eczema were 3.3, 1.7, and 3.3%, respectively, in children with FMF, whereas the corresponding prevalences in the ISAAC study were 6.9, 8.2, and 2.2%, respectively. Only the prevalence of allergic rhinitis was significantly different between the two groups (p&lt;0.001). The prevalence of atopy in these patients with FMF (4/60 (7%)) was significantly lower than in the children of the population based study (20.6%) (p&lt;0.001). Conclusion: Family Mediterranean fever seems to be protective against development of atopic sensitisation and allergic rhinitis.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.2003.007013</identifier><identifier>PMID: 14722209</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>allergic rhinitis ; Allergies ; Asthma ; Asthma - complications ; Asthma - epidemiology ; atopy ; Biological and medical sciences ; C reactive protein ; Child ; Child, Preschool ; Confidence intervals ; CRP ; Cytokines ; Dermatitis ; Dermatitis, Atopic - complications ; Dermatitis, Atopic - epidemiology ; Disease ; Diseases of the osteoarticular system ; Enzymes ; erythrocyte sedimentation rate ; ESR ; Extended Report ; familial Mediterranean fever ; Familial Mediterranean Fever - complications ; Female ; Fever ; FMF ; Humans ; Hypersensitivity - complications ; Hypersensitivity - diagnosis ; Hypersensitivity - epidemiology ; IFNγ ; interferon gamma ; interleukin ; International Study of Asthma and Allergies in Childhood ; ISAAC ; Male ; Medical sciences ; Mediterranean fever gene ; MEFV ; Mutation ; Parents &amp; parenting ; Pathogenesis ; Population ; Prevalence ; Questionnaires ; rheumatoid arthritis ; Rhinitis - complications ; Rhinitis - epidemiology ; Skin Tests ; Statistical analysis ; Studies ; T helper 1 ; T helper 2 ; Th1 ; Th2</subject><ispartof>Annals of the rheumatic diseases, 2004-02, Vol.63 (2), p.187-190</ispartof><rights>Copyright 2004 by Annals of the Rheumatic Diseases</rights><rights>2004 INIST-CNRS</rights><rights>COPYRIGHT 2004 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2004 Copyright 2004 by Annals of the Rheumatic Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b625t-1b60bb4e35c3372b155ee270f74664dd9f8107b083c16dcb442047f0e704f0593</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754884/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754884/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15437336$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14722209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sackesen, C</creatorcontrib><creatorcontrib>Bakkaloglu, A</creatorcontrib><creatorcontrib>Sekerel, B E</creatorcontrib><creatorcontrib>Ozaltin, F</creatorcontrib><creatorcontrib>Besbas, N</creatorcontrib><creatorcontrib>Yilmaz, E</creatorcontrib><creatorcontrib>Adalioglu, G</creatorcontrib><creatorcontrib>Ozen, S</creatorcontrib><title>Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Background: A number of inflammatory diseases, including familial Mediterranean fever (FMF), have been shown to be driven by a strongly dominated Th1 response, whereas the pathogenesis of atopic diseases is associated with a Th2 response. Objective: Because dominance of interferon gamma has the potential of inhibiting Th2 type responses—that is, development of allergic disorders, to investigate whether FMF, or mutations of the MEFV gene, have an effect on allergic diseases and atopy that are associated with an increased Th2 activity. Method: Sixty children with FMF were questioned about allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis, as were first degree relatives, using the ISAAC Study phase II questionnaire. The ISAAC Study phase II was performed in a similar ethnic group recruited from central Anatolia among 3041 children. The same skin prick test panel used for the ISAAC Study was used to investigate the presence of atopy in patients with FMF and included common allergens. Results: The prevalences of doctor diagnosed asthma, allergic rhinitis, and eczema were 3.3, 1.7, and 3.3%, respectively, in children with FMF, whereas the corresponding prevalences in the ISAAC study were 6.9, 8.2, and 2.2%, respectively. Only the prevalence of allergic rhinitis was significantly different between the two groups (p&lt;0.001). The prevalence of atopy in these patients with FMF (4/60 (7%)) was significantly lower than in the children of the population based study (20.6%) (p&lt;0.001). Conclusion: Family Mediterranean fever seems to be protective against development of atopic sensitisation and allergic rhinitis.</description><subject>allergic rhinitis</subject><subject>Allergies</subject><subject>Asthma</subject><subject>Asthma - complications</subject><subject>Asthma - epidemiology</subject><subject>atopy</subject><subject>Biological and medical sciences</subject><subject>C reactive protein</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Confidence intervals</subject><subject>CRP</subject><subject>Cytokines</subject><subject>Dermatitis</subject><subject>Dermatitis, Atopic - complications</subject><subject>Dermatitis, Atopic - epidemiology</subject><subject>Disease</subject><subject>Diseases of the osteoarticular system</subject><subject>Enzymes</subject><subject>erythrocyte sedimentation rate</subject><subject>ESR</subject><subject>Extended Report</subject><subject>familial Mediterranean fever</subject><subject>Familial Mediterranean Fever - complications</subject><subject>Female</subject><subject>Fever</subject><subject>FMF</subject><subject>Humans</subject><subject>Hypersensitivity - complications</subject><subject>Hypersensitivity - diagnosis</subject><subject>Hypersensitivity - epidemiology</subject><subject>IFNγ</subject><subject>interferon gamma</subject><subject>interleukin</subject><subject>International Study of Asthma and Allergies in Childhood</subject><subject>ISAAC</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mediterranean fever gene</subject><subject>MEFV</subject><subject>Mutation</subject><subject>Parents &amp; parenting</subject><subject>Pathogenesis</subject><subject>Population</subject><subject>Prevalence</subject><subject>Questionnaires</subject><subject>rheumatoid arthritis</subject><subject>Rhinitis - complications</subject><subject>Rhinitis - epidemiology</subject><subject>Skin Tests</subject><subject>Statistical analysis</subject><subject>Studies</subject><subject>T helper 1</subject><subject>T helper 2</subject><subject>Th1</subject><subject>Th2</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkk1vEzEQhlcIREPhzA2thOCAtOn4Y-3dS6UqpRQRyqX0anm949Rhv7A3afvvcZSooSgS2oPXnmdez4zfJHlLYEoIEyfa11MKwKYAEgh7lkwIF0VGQcDzZAIxkvFSyKPkVQjLuIWCFC-TI8IlpRTKSXJzjsajDling8e1brAzmPY21WM_PKSuSweNtdOjdyb-jg67MaR3brxNrW5d43STfo_AiN7rDnWXWlyjf528sLoJ-Ga3Hic_Lz5fzy6z-Y8vX2dn86wSNB8zUgmoKo4sN4xJWpE8R6QSrORC8LoubUFAVlAwQ0RtKs4pcGkBJXALecmOk9Ot7rCqWqxNrM7rRg3etdo_qF479TTSuVu16NeKyJwXBY8CH3cCvv-9wjCq1gWDTROb6VdBFQAlYWQDvv8HXPYr38XmopaUBc9LQffUIk5Suc728VazkVRnhNCSE0EgUtkBaoEdxhL7Dq2Lx0_46QE-fjW2zhxMONkmGN-H4NE-ToSA2hhHReOojXHU1jgx493fg9zzO6dE4MMO0MHoxsbXNi7suZwzyZjY9-bCiPePce1_KSGZzNXVzUyVxfzy_NvFtbqK_KctX7XL_1b5BzUp5WI</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>Sackesen, C</creator><creator>Bakkaloglu, A</creator><creator>Sekerel, B E</creator><creator>Ozaltin, F</creator><creator>Besbas, N</creator><creator>Yilmaz, E</creator><creator>Adalioglu, G</creator><creator>Ozen, S</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20040201</creationdate><title>Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever</title><author>Sackesen, C ; Bakkaloglu, A ; Sekerel, B E ; Ozaltin, F ; Besbas, N ; Yilmaz, E ; Adalioglu, G ; Ozen, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b625t-1b60bb4e35c3372b155ee270f74664dd9f8107b083c16dcb442047f0e704f0593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>allergic rhinitis</topic><topic>Allergies</topic><topic>Asthma</topic><topic>Asthma - complications</topic><topic>Asthma - epidemiology</topic><topic>atopy</topic><topic>Biological and medical sciences</topic><topic>C reactive protein</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Confidence intervals</topic><topic>CRP</topic><topic>Cytokines</topic><topic>Dermatitis</topic><topic>Dermatitis, Atopic - complications</topic><topic>Dermatitis, Atopic - epidemiology</topic><topic>Disease</topic><topic>Diseases of the osteoarticular system</topic><topic>Enzymes</topic><topic>erythrocyte sedimentation rate</topic><topic>ESR</topic><topic>Extended Report</topic><topic>familial Mediterranean fever</topic><topic>Familial Mediterranean Fever - complications</topic><topic>Female</topic><topic>Fever</topic><topic>FMF</topic><topic>Humans</topic><topic>Hypersensitivity - complications</topic><topic>Hypersensitivity - diagnosis</topic><topic>Hypersensitivity - epidemiology</topic><topic>IFNγ</topic><topic>interferon gamma</topic><topic>interleukin</topic><topic>International Study of Asthma and Allergies in Childhood</topic><topic>ISAAC</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mediterranean fever gene</topic><topic>MEFV</topic><topic>Mutation</topic><topic>Parents &amp; parenting</topic><topic>Pathogenesis</topic><topic>Population</topic><topic>Prevalence</topic><topic>Questionnaires</topic><topic>rheumatoid arthritis</topic><topic>Rhinitis - complications</topic><topic>Rhinitis - epidemiology</topic><topic>Skin Tests</topic><topic>Statistical analysis</topic><topic>Studies</topic><topic>T helper 1</topic><topic>T helper 2</topic><topic>Th1</topic><topic>Th2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sackesen, C</creatorcontrib><creatorcontrib>Bakkaloglu, A</creatorcontrib><creatorcontrib>Sekerel, B E</creatorcontrib><creatorcontrib>Ozaltin, F</creatorcontrib><creatorcontrib>Besbas, N</creatorcontrib><creatorcontrib>Yilmaz, E</creatorcontrib><creatorcontrib>Adalioglu, G</creatorcontrib><creatorcontrib>Ozen, S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sackesen, C</au><au>Bakkaloglu, A</au><au>Sekerel, B E</au><au>Ozaltin, F</au><au>Besbas, N</au><au>Yilmaz, E</au><au>Adalioglu, G</au><au>Ozen, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2004-02-01</date><risdate>2004</risdate><volume>63</volume><issue>2</issue><spage>187</spage><epage>190</epage><pages>187-190</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background: A number of inflammatory diseases, including familial Mediterranean fever (FMF), have been shown to be driven by a strongly dominated Th1 response, whereas the pathogenesis of atopic diseases is associated with a Th2 response. Objective: Because dominance of interferon gamma has the potential of inhibiting Th2 type responses—that is, development of allergic disorders, to investigate whether FMF, or mutations of the MEFV gene, have an effect on allergic diseases and atopy that are associated with an increased Th2 activity. Method: Sixty children with FMF were questioned about allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis, as were first degree relatives, using the ISAAC Study phase II questionnaire. The ISAAC Study phase II was performed in a similar ethnic group recruited from central Anatolia among 3041 children. The same skin prick test panel used for the ISAAC Study was used to investigate the presence of atopy in patients with FMF and included common allergens. Results: The prevalences of doctor diagnosed asthma, allergic rhinitis, and eczema were 3.3, 1.7, and 3.3%, respectively, in children with FMF, whereas the corresponding prevalences in the ISAAC study were 6.9, 8.2, and 2.2%, respectively. Only the prevalence of allergic rhinitis was significantly different between the two groups (p&lt;0.001). The prevalence of atopy in these patients with FMF (4/60 (7%)) was significantly lower than in the children of the population based study (20.6%) (p&lt;0.001). Conclusion: Family Mediterranean fever seems to be protective against development of atopic sensitisation and allergic rhinitis.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><pmid>14722209</pmid><doi>10.1136/ard.2003.007013</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2004-02, Vol.63 (2), p.187-190
issn 0003-4967
1468-2060
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754884
source PubMed Central
subjects allergic rhinitis
Allergies
Asthma
Asthma - complications
Asthma - epidemiology
atopy
Biological and medical sciences
C reactive protein
Child
Child, Preschool
Confidence intervals
CRP
Cytokines
Dermatitis
Dermatitis, Atopic - complications
Dermatitis, Atopic - epidemiology
Disease
Diseases of the osteoarticular system
Enzymes
erythrocyte sedimentation rate
ESR
Extended Report
familial Mediterranean fever
Familial Mediterranean Fever - complications
Female
Fever
FMF
Humans
Hypersensitivity - complications
Hypersensitivity - diagnosis
Hypersensitivity - epidemiology
IFNγ
interferon gamma
interleukin
International Study of Asthma and Allergies in Childhood
ISAAC
Male
Medical sciences
Mediterranean fever gene
MEFV
Mutation
Parents & parenting
Pathogenesis
Population
Prevalence
Questionnaires
rheumatoid arthritis
Rhinitis - complications
Rhinitis - epidemiology
Skin Tests
Statistical analysis
Studies
T helper 1
T helper 2
Th1
Th2
title Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A39%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20prevalence%20of%20atopy%20in%20paediatric%20patients%20with%20familial%20Mediterranean%20fever&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Sackesen,%20C&rft.date=2004-02-01&rft.volume=63&rft.issue=2&rft.spage=187&rft.epage=190&rft.pages=187-190&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.2003.007013&rft_dat=%3Cgale_pubme%3EA112941610%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b625t-1b60bb4e35c3372b155ee270f74664dd9f8107b083c16dcb442047f0e704f0593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777845962&rft_id=info:pmid/14722209&rft_galeid=A112941610&rfr_iscdi=true